MYGN Annual Total Liabilities
$363.30 M
+$50.40 M+16.11%
01 December 2023
Summary:
As of January 22, 2025, MYGN annual total liabilities is $363.30 million, with the most recent change of +$50.40 million (+16.11%) on December 1, 2023. During the last 3 years, it has fallen by -$174.50 million (-32.45%). MYGN annual total liabilities is now -32.45% below its all-time high of $537.80 million, reached on December 1, 2020.MYGN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MYGN Quarterly Total Liabilities
$349.60 M
+$5.00 M+1.45%
01 September 2024
Summary:
As of January 22, 2025, MYGN quarterly total liabilities is $349.60 million, with the most recent change of +$5.00 million (+1.45%) on September 1, 2024. Over the past year, it has dropped by -$900.00 thousand (-0.26%). MYGN quarterly total liabilities is now -35.66% below its all-time high of $543.40 million, reached on December 31, 2016.MYGN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MYGN Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.1% | -0.3% |
| 3 y3 years | -32.5% | +11.7% |
| 5 y5 years | -23.3% | -30.2% |
MYGN Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.1% | -24.9% | +33.0% |
| 5 y | 5-year | -32.5% | +16.1% | -34.7% | +33.0% |
| alltime | all time | -32.5% | +6627.8% | -35.7% | +6496.2% |
Myriad Genetics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $349.60 M(+1.5%) |
| June 2024 | - | $344.60 M(-1.7%) |
| Mar 2024 | - | $350.50 M(-3.5%) |
| Dec 2023 | $363.30 M(+16.1%) | $363.30 M(-22.0%) |
| Sept 2023 | - | $465.70 M(+3.0%) |
| June 2023 | - | $452.00 M(+35.3%) |
| Mar 2023 | - | $334.10 M(+6.8%) |
| Dec 2022 | $312.90 M(-11.3%) | $312.90 M(+5.9%) |
| Sept 2022 | - | $295.40 M(+12.4%) |
| June 2022 | - | $262.80 M(-13.9%) |
| Mar 2022 | - | $305.30 M(-13.5%) |
| Dec 2021 | $352.90 M(-34.4%) | $352.90 M(-3.9%) |
| Sept 2021 | - | $367.40 M(-19.8%) |
| June 2021 | - | $457.90 M(-0.8%) |
| Mar 2021 | - | $461.70 M(-13.7%) |
| Dec 2020 | $537.80 M(+10.6%) | - |
| Sept 2020 | - | $535.20 M(+10.0%) |
| June 2020 | $486.40 M(+2.7%) | $486.40 M(+1.4%) |
| Mar 2020 | - | $479.50 M(-4.3%) |
| Dec 2019 | - | $501.00 M(-3.0%) |
| Sept 2019 | - | $516.70 M(+9.1%) |
| June 2019 | $473.80 M(+126.5%) | $473.80 M(-0.4%) |
| Mar 2019 | - | $475.60 M(-3.4%) |
| Dec 2018 | - | $492.50 M(+4.5%) |
| Sept 2018 | - | $471.40 M(+125.3%) |
| June 2018 | $209.20 M(-52.6%) | $209.20 M(-22.5%) |
| Mar 2018 | - | $270.10 M(-14.1%) |
| Dec 2017 | - | $314.30 M(-12.1%) |
| Sept 2017 | - | $357.70 M(-18.9%) |
| June 2017 | $440.90 M(+233.0%) | $440.90 M(-15.2%) |
| Mar 2017 | - | $519.90 M(-4.3%) |
| Dec 2016 | - | $543.40 M(+1.5%) |
| Sept 2016 | - | $535.60 M(+304.5%) |
| June 2016 | $132.40 M(+27.2%) | $132.40 M(+35.1%) |
| Mar 2016 | - | $98.00 M(-2.9%) |
| Dec 2015 | - | $100.90 M(+1.0%) |
| Sept 2015 | - | $99.90 M(-4.0%) |
| June 2015 | $104.10 M(-0.7%) | $104.10 M(-5.5%) |
| Mar 2015 | - | $110.15 M(+25.7%) |
| Dec 2014 | - | $87.61 M(-9.5%) |
| Sept 2014 | - | $96.86 M(-7.6%) |
| June 2014 | $104.80 M(+39.3%) | $104.80 M(+11.3%) |
| Mar 2014 | - | $94.18 M(+16.7%) |
| Dec 2013 | - | $80.71 M(-11.7%) |
| Sept 2013 | - | $91.39 M(+21.5%) |
| June 2013 | $75.23 M(+36.8%) | $75.23 M(+17.4%) |
| Mar 2013 | - | $64.10 M(+15.2%) |
| Dec 2012 | - | $55.63 M(-17.6%) |
| Sept 2012 | - | $67.49 M(+22.8%) |
| June 2012 | $54.98 M(+24.8%) | $54.98 M(+16.8%) |
| Mar 2012 | - | $47.06 M(+5.8%) |
| Dec 2011 | - | $44.49 M(+9.2%) |
| Sept 2011 | - | $40.74 M(-7.5%) |
| June 2011 | $44.03 M(+21.4%) | $44.03 M(+34.2%) |
| Mar 2011 | - | $32.82 M(+1.0%) |
| Dec 2010 | - | $32.51 M(-18.2%) |
| Sept 2010 | - | $39.73 M(+9.6%) |
| June 2010 | $36.27 M | $36.27 M(+63.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $22.22 M(-2.2%) |
| Dec 2009 | - | $22.71 M(+8.2%) |
| Sept 2009 | - | $20.99 M(-34.7%) |
| June 2009 | $32.17 M(-56.3%) | $32.17 M(-11.9%) |
| Mar 2009 | - | $36.50 M(-32.2%) |
| Dec 2008 | - | $53.82 M(-0.7%) |
| Sept 2008 | - | $54.18 M(-26.5%) |
| June 2008 | $73.69 M(+109.5%) | $73.69 M(+95.7%) |
| Mar 2008 | - | $37.66 M(+7.9%) |
| Dec 2007 | - | $34.89 M(+10.3%) |
| Sept 2007 | - | $31.62 M(-10.1%) |
| June 2007 | $35.18 M(+31.1%) | $35.18 M(+53.2%) |
| Mar 2007 | - | $22.96 M(-13.3%) |
| Dec 2006 | - | $26.47 M(+15.4%) |
| Sept 2006 | - | $22.95 M(-14.4%) |
| June 2006 | $26.82 M(+15.2%) | $26.82 M(+24.2%) |
| Mar 2006 | - | $21.59 M(-8.4%) |
| Dec 2005 | - | $23.58 M(+5.5%) |
| Sept 2005 | - | $22.35 M(-4.0%) |
| June 2005 | $23.29 M(+54.4%) | $23.29 M(+40.8%) |
| Mar 2005 | - | $16.54 M(-4.7%) |
| Dec 2004 | - | $17.36 M(+25.2%) |
| Sept 2004 | - | $13.86 M(-8.1%) |
| June 2004 | $15.08 M(-22.0%) | $15.08 M(+1.6%) |
| Mar 2004 | - | $14.84 M(+15.1%) |
| Dec 2003 | - | $12.89 M(+5.6%) |
| Sept 2003 | - | $12.21 M(-36.9%) |
| June 2003 | $19.34 M(-32.2%) | $19.34 M(+49.7%) |
| Mar 2003 | - | $12.92 M(-40.4%) |
| Dec 2002 | - | $21.67 M(+34.7%) |
| Sept 2002 | - | $16.09 M(-43.6%) |
| June 2002 | $28.52 M(-12.5%) | $28.52 M(+50.7%) |
| Mar 2002 | - | $18.93 M(-7.0%) |
| Dec 2001 | - | $20.36 M(-7.3%) |
| Sept 2001 | - | $21.97 M(-32.6%) |
| June 2001 | $32.58 M(+13.7%) | $32.58 M(+41.6%) |
| Mar 2001 | - | $23.01 M(+6.0%) |
| Dec 2000 | - | $21.70 M(-9.7%) |
| Sept 2000 | - | $24.03 M(-16.2%) |
| June 2000 | $28.67 M(+430.9%) | $28.67 M(+26.8%) |
| Mar 2000 | - | $22.62 M(+22.9%) |
| Dec 1999 | - | $18.40 M(+28.7%) |
| Sept 1999 | - | $14.30 M(+164.8%) |
| June 1999 | $5.40 M(-45.5%) | $5.40 M(-6.9%) |
| Mar 1999 | - | $5.80 M(-12.1%) |
| Dec 1998 | - | $6.60 M(-15.4%) |
| Sept 1998 | - | $7.80 M(-21.2%) |
| June 1998 | $9.90 M(0.0%) | $9.90 M(+7.6%) |
| Mar 1998 | - | $9.20 M(-6.1%) |
| Dec 1997 | - | $9.80 M(-2.0%) |
| Sept 1997 | - | $10.00 M(+1.0%) |
| June 1997 | $9.90 M(+5.3%) | $9.90 M(+13.8%) |
| Mar 1997 | - | $8.70 M(-9.4%) |
| Dec 1996 | - | $9.60 M(-4.0%) |
| Sept 1996 | - | $10.00 M(+6.4%) |
| June 1996 | $9.40 M | $9.40 M(+1.1%) |
| Mar 1996 | - | $9.30 M(+75.5%) |
| Dec 1995 | - | $5.30 M |
FAQ
- What is Myriad Genetics annual total liabilities?
- What is the all time high annual total liabilities for Myriad Genetics?
- What is Myriad Genetics annual total liabilities year-on-year change?
- What is Myriad Genetics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Myriad Genetics?
- What is Myriad Genetics quarterly total liabilities year-on-year change?
What is Myriad Genetics annual total liabilities?
The current annual total liabilities of MYGN is $363.30 M
What is the all time high annual total liabilities for Myriad Genetics?
Myriad Genetics all-time high annual total liabilities is $537.80 M
What is Myriad Genetics annual total liabilities year-on-year change?
Over the past year, MYGN annual total liabilities has changed by +$50.40 M (+16.11%)
What is Myriad Genetics quarterly total liabilities?
The current quarterly total liabilities of MYGN is $349.60 M
What is the all time high quarterly total liabilities for Myriad Genetics?
Myriad Genetics all-time high quarterly total liabilities is $543.40 M
What is Myriad Genetics quarterly total liabilities year-on-year change?
Over the past year, MYGN quarterly total liabilities has changed by -$900.00 K (-0.26%)